Skip to main content

Altimmune, Inc. (NASDAQ: ALT) Investor Securities Class Action Lawsuit 05/06/2024

  • If you purchased a significant amount of shares of Altimmune, Inc. (NASDAQ: ALT) between December 1, 2023 and April 26, 2024, and / or if you purchased any NASDAQ: ALT shares prior to December 2023 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: July 5, 2024. NASDAQ: ALT investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

May 06, 2024 - An investor in shares of Altimmune, Inc. (NASDAQ: ALT) filed a lawsuit in the U.S. District Court for the District of Maryland over alleged violations of Federal Securities Laws by Altimmune, Inc. in connection with certain allegedly false and misleading statements made between December 1, 2023 and April 26, 2024. Gaithersburg, MD based Altimmune, Inc., a clinical stage...

You must register (for free) or login to view the entire case.